Safety and Tolerability of Intra-Articular Injection of Adipose-Derived Mesenchymal Stem Cells GXCPC1 in 11 Subjects With Knee Osteoarthritis: A Nonrandomized Pilot Study Without a Control Arm.

Authors:
Chen CF; Chen YC; Fu YS; Tsai SW; Wu PK and 9 more

Journal:
Cell Transplant

Publication Year: 2024

DOI:
10.1177/09636897231221882

PMCID:
PMC10785714

PMID:
38205679

Journal Information

Full Title: Cell Transplant

Abbreviation: Cell Transplant

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Transplantation

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grant from the Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan."

Evidence found in paper:

"Clinical Trial Notation: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis (NCT03943576)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025